The REDEFINE trials have shown that CagriSema confers clinically significant weight loss (approximately 20% of total body weight) compared with placebo, in both people with and without type 2 diabetes
While semaglutide injections offer a promising weight loss option, understanding the costs involved is crucial, especially in Gilbert, AZ
Tirzepatide (Mounjaro) has also received MHRA approval and a positive NICE recommendation for weight management in adults (NICE TA1026), with NHS eligibility subject to defined BMI and comorbidity criteria within specialist services
Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease: Review
Visit our website to sign up
Arinno A, Apaijai N, Kaewtep P et al (2019) Combined low-dose testosterone and vildagliptin confers cardioprotection in castrated obese rats